IL6 and COVID-19: In COVID-19 patients, it has been hypothesized that the high levels of IL-6, IL-8 and IL-10 released by multiple cell types at the site of SARS-CoV-2 infection may alter the number and function of NK cells and neutrophils, thus compromising their mutual equilibrium (104).